SYNOPSIS A controlled trial of continuous chelation therapy in regularly transfused children with homozygous fl-thalassaemia has been in progress at the Hospital for Sick Children since April 1966. In the sixth and seventh years of the trial the effect of this treatment on iron overload has been assessed by estimating serum ferritin levels and liver iron concentrations in both chelator-treated and control groups. When compared with non-chelated controls, results of both these estimations were invariably lower in the chelated group. However, all the results in both groups were very high, and fell within the ranges observed in untreated idiopathic haemochromatosis. A close correlation was found between serum ferritin levels and liver iron concentrations in these children, indicating that serum ferritin is a valuable alternative to liver iron concentration in the assessment of visceral iron overload, even when massive tissue siderosis is present.Without blood transfusion the majority of patients with homozygous P-thalassaemia die from anaemia in early childhood. With regular transfusions, however, survival is prolonged into adolescence or early adult life (Weatherall and Clegg, 1972). The major problem in management, and the chief factor limiting life in these patients, then becomes that of iron overload, the excess iron being derived predominantly from transfused red blood cells.Parenteral chelating agents have been used in thalassaemia in an attempt to promote mobilization and excretion of the excess iron but at present there is little information regarding their real value in this condition. A prospective trial of long-term chelation therapy in regularly transfused children with homozygous thalassaemia was started at the Hospital for Sick Children in 1966. During the sixth and seventh years of the trial serum ferritin levels were measured in both chelator-treated patients and in untreated controls. The results of these estimations have been compared with liver iron concentrations in the same patients, and serum ferritin levels have also been determined in other regularly transfused thalassaemic children not included in the trial. The results obtained provide information regarding the effects of chelation therapy and the value of the serum ferritin level as a measure of iron overload in thalassaemia.